Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

138.38
+0.92000.67%
Volume:356.71K
Turnover:49.37M
Market Cap:264.03B
PE:20.92
High:138.91
Open:138.77
Low:138.08
Close:137.48
52wk High:170.46
52wk Low:121.57
Shares:1.91B
Float Shares:1.85B
Volume Ratio:1.21
T/O Rate:0.02%
Dividend:4.67
Dividend Rate:3.37%
EPS(TTM):6.61
EPS(LYR):7.15
ROE:30.35%
ROA:10.25%
PB:6.36
PE(LYR):19.35

Loading ...

Novartis Might Need More Deals to Deliver Growth Ambitions

Dow Jones
·
Sep 08

Why the Dow is Being Dragged Down by a Swiss Company's Bad News

Dow Jones
·
Sep 08

Novartis AG Falls 13% in Pre-Market Trading, DM1 Drug Phase III Clinical Trial Fails to Meet Primary Endpoint

Market Focus
·
Sep 08

Novartis's Latest Trial Setback Sinks Stock

Dow Jones
·
Sep 08

Novartis Genetic Muscle Disorder Drug Fails Phase 3 Trial; Shares Drop Pre-Bell

MT Newswires Live
·
Sep 08

The Inflammation Bet Unravels: Novo And Novartis Both Stumble In Cardiovascular

Bellwether Stocks Movement
·
Sep 08

United Natural Foods, ABM Industries and 3 Stocks to Watch Heading Into Tuesday

Benzinga Earnings
·
Sep 08

Novartis's Latest Trial Failure is Second Pipeline Setback in a Row

Dow Jones
·
Sep 08

Movement Alert|Novartis AG Falls 4.16% Overnight, Phase III Heart Disease Drug Pelacarsen Fails Key Cardiovascular Trial

Market Focus
·
Sep 08

European Equities Remain Flat as Energy Gains Offset by Pharma Slump

Deep News
·
Sep 08

Novartis AG Falls Monday, Underperforms Market

Dow Jones
·
Sep 08

Citi says Novartis news increases likelihood Crispr prioritizes next-gen CTX321

TIPRANKS
·
Sep 07

Citi sees limited immediate downside for Ionis after pelacarsen failure

TIPRANKS
·
Sep 07

BofA sees low single-digit percentage downside for Novartis on pelacarsen miss

TIPRANKS
·
Sep 07

Novartis Shares Fall After Heart Drug Misses Target in Late-Stage Trial

Dow Jones
·
Sep 07

Novartis India to Acquire 'Minipress' Trademarks from Pfizer

Reuters
·
Sep 07

Second Clinical Trial Blow in a Week for Novartis as Heart Drug Disappoints, Dragging Down Amgen Shares

Stock News
·
Sep 07

Novartis Heart-Trial Failure Could be Mitigated by Investor Caution

Dow Jones
·
Sep 07

Novartis India - Deal Valued at 12.50 Bln Rupees

THOMSON REUTERS
·
Sep 07

Novartis Shares to Take Hit from Cholesterol Trial Failure

Dow Jones
·
Sep 07